絞り込み

16555

広告

Unit-Dose Packaging and Unintentional Buprenorphine-Naloxone Exposures.

著者 Wang GS , Severtson SG , Bau GE , Dart RC , Green JL
Pediatrics.2018 May 03 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (16view , 0users)

Full Text Sources

Buprenorphine accounts for the most opioid-related pediatric hospital admissions when compared with other opioid analgesics. Since 2010, several manufacturers began distributing their buprenorphine products with unit-dose packaging (UDP). Our main objective in this study is to evaluate the impact of UDP on unintentional pediatric buprenorphine-naloxone poison center exposures.
PMID: 29724879 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード